Search Results - "Zongfei, Ji"

Refine Results
  1. 1

    Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study by Kong, Xiufang, Sun, Ying, Dai, Xiaojuan, Wang, Li, Ji, Zongfei, Chen, Huiyong, Jin, Xuejuan, Ma, Lili, Jiang, Lindi

    Published in Annals of the rheumatic diseases (01-01-2022)
    “…To compare the treatment efficacy and safety of tofacitinib (TOF) versus methotrexate (MTX) in Takayasu arteritis (TAK). Fifty-three patients with active…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system by Ji, Zongfei, Lin, Gaofeng, Lu, Qinghua, Meng, Lingjie, Shen, Xizhong, Dong, Ling, Fu, Chuanlong, Zhang, Xiaoke

    “…A highly effective targeted DDS based on chitosan and folic acid modified single walled carbon nanotubes for controllable loading/release of anti-cancer agent…”
    Get full text
    Journal Article
  4. 4

    Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study by Zongfei, Ji, Lingying, Ma, Lijuan, Zhang, Ying, Sun, Rongyi, Chen, Dongmei, Liu, Xiufang, Kong, Xiaomin, Dai, Lili, Ma, Huiyong, Chen, Lindi, Jiang

    Published in Clinical rheumatology (01-06-2021)
    “…Objectives Patients with IgG4-related disease (IgG4-RD) suffer high relapse rates during long-term treatment, but factors that predict relapse outcomes are not…”
    Get full text
    Journal Article
  5. 5

    Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China by Kong, Xiufang, Ma, Lili, Lv, Peng, Cui, Xiaomeng, Chen, Rongyi, Ji, Zongfei, Chen, Huiyong, Lin, Jiang, Jiang, Lindi

    Published in Arthritis research & therapy (05-06-2020)
    “…Abstract Background Takayasu arteritis (TA) is a large vessel vasculitis that can involve pulmonary arteries (PAs). We studied multiple clinical…”
    Get full text
    Journal Article
  6. 6

    Clinical and pathological predictors of relapse in IgG4-related disease by Zongfei, Ji, Lingli, Chen, Ying, Sun, Lingying, Ma, Lijuan, Zhang, Dongmei, Liu, Xiaomin, Dai, Yingyong, Hou, Huiyong, Chen, Lili, Ma, Lindi, Jiang

    Published in Arthritis research & therapy (11-05-2022)
    “…In IgG4-related disease, the relationship between pathological findings and relapse has not been well established. This study aimed to identify the clinical…”
    Get full text
    Journal Article
  7. 7

    Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis by Chen, Rongyi, Ma, Lingying, Lv, Peng, Lin, Jiang, Li, Chaolun, Yan, Yan, Jin, Xuejuan, Dai, Xiaomin, Ji, Zongfei, Chen, Huiyong, Ma, Lili, Sun, Ying, Jiang, Lindi

    Published in Arthritis research & therapy (24-02-2021)
    “…Takayasu arteritis (TA) is a rare disease, lacking convenient and feasible biomarkers to identify disease activity. We aimed to evaluate the value of…”
    Get full text
    Journal Article
  8. 8

    A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis by Kong, Xiufang, Wu, Sifan, Dai, Xiaojuan, Yu, Wensu, Wang, Jinghua, Sun, Ying, Ji, Zongfei, Ma, Lingying, Dai, Xiaomin, Chen, Huiyong, Ma, Lili, Jiang, Lindi

    Published in Arthritis research & therapy (16-02-2022)
    “…Takayasu arteritis (TAK) is a chronic granulomatous large vessel vasculitis with multiple immune cells involved. Chemokines play critical roles in recruitment…”
    Get full text
    Journal Article
  9. 9

    Single-Cell RNA-Sequencing Reveals Peripheral T Helper Cells Promoting the Development of IgG4-Related Disease by Enhancing B Cell Activation and Differentiation by Ji, Zongfei, Lu, Weiqi, Wu, Sifan, Zhang, Yong, Meng, Dan, Zhang, Xiao, Dai, Xiaojuan, Chen, Huiyong, Ma, Lili, Sun, Ying, Jiang, Lindi, Kong, Xiufang

    “…Abnormal B cell differentiation plays a critical role in IgG4-related disease (IgG4-RD), but the underlying mechanism remains largely unknown. We investigated…”
    Get full text
    Journal Article
  10. 10

    Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis by Wu, Chunling, Sun, Ying, Cui, Xiaomeng, Wu, Sifan, Ma, Lili, Chen, Huiyong, Yan, Yan, Ji, Zongfei, Liu, Yun, Lin, Jiang, Lv, Peng, Chen, Rongyi, Yang, Pingting, Jiang, Lindi

    “…Aims: The study investigates the effectiveness and safety of methotrexate (MTX) versus leflunomide (LEF) in 12-month treatment of Takayasu arteritis (TAK)…”
    Get full text
    Journal Article
  11. 11

    Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study by Ying, Sun, Xiaomeng, Cui, Xiaomin, Dai, Jiang, Lin, Peng, Lv, Lili, Ma, Rongyi, Chen, Zongfei, Ji, Huiyong, Chen, Lindi, Jiang

    “…Background: Leflunomide (LEF) has been considered as an alternative treatment for Takayasu arteritis (TA); however, data on its efficacy are still scanty…”
    Get full text
    Journal Article
  12. 12

    The hepatotoxicity of multi-walled carbon nanotubes in mice by Ji, Zongfei, Zhang, Danying, Li, Ling, Shen, Xizhong, Deng, Xiaoyong, Dong, Ling, Wu, Minhong, Liu, Yuanfang

    Published in Nanotechnology (04-11-2009)
    “…The hepatotoxicity of two types of multi-walled carbon nanotubes (MWCNTs), acid-oxidized MWCNTs (O-MWCNTs) and Tween-80-dispersed MWCNTs (T-MWCNTs), were…”
    Get more information
    Journal Article
  13. 13

    Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis by Rongyi, Chen, Zongfei, Ji, Jiang, Lin, Sifan, Wu, Lingying, Ma, Ying, Sun, Wenshu, Yu, Xiaomeng, Cui, Xiufang, Kong, Xiaomin, Dai, Lili, Ma, Yanshan, Li, Lindi, Jiang

    Published in Modern rheumatology (02-11-2021)
    “…Hydroxychloroquine (HCQ), an anti-malarial drug, is widely used in the treatment of rheumatic diseases. However, the benefits of HCQ in the treatment of…”
    Get full text
    Journal Article
  14. 14

    In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease by Zongfei, Ji, Rongyi, Chen, Xiaomeng, Cui, Lili, Ma, Lingying, Ma, Xiufang, Kong, Xiaomin, Dai, Zhuojun, Zhang, Huiyong, Chen, Ying, Sun, Lindi, Jiang

    Published in Frontiers in immunology (08-07-2020)
    “…The remarkable mechanisms of storiform fibrosis and the formation of high levels of IgG4 with a pathogenic germinal center (GC) in the inflammatory tissue of…”
    Get full text
    Journal Article
  15. 15

    Long-term hepatotoxicity of polyethylene-glycol functionalized multi-walled carbon nanotubes in mice by Zhang, Danying, Deng, Xiaoyong, Ji, Zongfei, Shen, Xizhong, Dong, Ling, Wu, Minghong, Gu, Taoying, Liu, Yuanfang

    Published in Nanotechnology (30-04-2010)
    “…The toxicity of polyethylene-glycol functionalized (PEGylated) multi-walled carbon nanotubes (MWCNTs) and non-PEGylated MWCNTs in vivo was evaluated and…”
    Get more information
    Journal Article
  16. 16

    Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry by Zongfei, Ji, Lijuan, Zhang, Ying, Sun, Dongmei, Liu, Sifan, Wu, Xiufang, Kong, Lingying, Ma, Yun, Liu, Lili, Ma, Huiyong, Chen, Lindi, Jiang

    “…Objective: To compare the clinical outcomes of patients with active immunoglobulin G (IgG) 4 related disease (IgG4-RD) receiving tocilizumab versus those…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Predictors of irreversible renal dysfunction in patients with idiopathic retroperitoneal fibrosis by Ji, Zongfei, Sun, Ying, Zhang, Lijuan, Kong, Xiufang, Jiang, Lindi

    Published in Rheumatology (Oxford, England) (26-10-2024)
    “…Idiopathic retroperitoneal fibrosis (iRPF) can lead to irreversible kidney damage. This study aimed to investigate predictors of irreversible renal dysfunction…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study by Wang, Jinghua, Dai, Xiaojuan, Ma, Lingying, Wu, Sifan, Jin, Xuejuan, Ji, Zongfei, Chen, Huiyong, Ma, Lili, Ding, Zhenqi, Jiang, Lindi, Kong, Xiufang

    Published in Seminars in arthritis and rheumatism (01-08-2022)
    “…To investigate the efficacy and safety of leflunomide (LEF) versus tofacitinib (TOF) in Takayasu arteritis (TAK) patients. Sixty-seven active patients were…”
    Get full text
    Journal Article